ICD-10 Coding for Antinuclear Antibody(M32.9U, M35.00U, R76.0)
Learn about ICD-10 coding for antinuclear antibodies, including elevated titers and specific patterns. Ensure accurate documentation and coding compliance.
Complete code families applicable to Antinuclear Antibody
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| R76.0 | Raised antibody titer | Use when ANA titer is elevated without specific pattern documentation. |
|
| R76.8 | Other specified abnormal immunological findings in serum | Use when specific ANA patterns are documented. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutAntinuclear Antibody
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Antinuclear Antibody.
Documenting 'Positive ANA' without specifics
Impact
Clinical: May lead to misdiagnosis or inappropriate treatment., Regulatory: Fails to meet documentation standards., Financial: Potential claim denials due to insufficient documentation.
Mitigation
Always include titer and pattern in documentation., Use templates to ensure completeness.
Using R76.0 without an autoimmune disease code
Impact
Reimbursement: May result in denied claims due to incomplete coding., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate representation of patient's condition.
Mitigation
Always pair R76.0 with a relevant autoimmune disease code.
Incomplete Documentation
Impact
Failure to document ANA titer and pattern can lead to audit issues.
Mitigation
Use standardized templates and ensure all required elements are documented.